An urologist explains why a PSA test is just the first step in the screening process for prostate cancer screenings. Learn what contributes to your PSA results.

Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...

THIS YEAR, IT'S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there's no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...

PSA testing may be the first step in prostate cancer screening, but benign factors may contribute to high PSA, including aging, infection, and more.

The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and ...

Dear Doctors: If my doctor won’t order a PSA or other screening test, can I pay for it myself? We are always told about the importance of early detection. So why aren’t screening tests recommended for ...

For a man who has been putting off a prostate check because he fears “the finger”, there is something worth knowing: prostate cancer screening can begin with a blood test. You do not have to agree to ...

Today was the day for my quarterly (or more precisely, 12-week) blood (PSA) test. I am checking the effectiveness of the ...

Two studies have found that using a mobile van for prostate-specific antigen (PSA) testing improves healthcare access for high-risk male patients from deprived communities and ethnic minorities.

OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch ® 3D genomics platform, today ...